CRB-913 brain levels are 15-fold lower than monlunabant in lean miceDose-response demonstrated for a range of 5 to 80 mg/kg/day achieving up to ...

The research study tested a murine equivalent of SRK-439 in a diet-induced obesity, or DIO, mouse model. All mice were given a high-fat diet, followed by either metformin or control for four weeks.

Preclinical study design The research study tested a murine equivalent of SRK-439 in a diet-induced obesity (DIO) mouse model. All mice were given a high-fat diet, followed by either metformin (50 ...

To investigate the response of reproductive tissues to hyperinsulinemia, we used a mouse model of infertility associated with DIO. Hence, it is likely that a hormonal milieu that differs between ...

Even if you're using one of the best wireless mice, heavy PC and laptop use can lead to wrist fatigue, wrist pain, and even conditions like carpal tunnel and repetitive strain injury. Although it ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

Cooler weather always brings a spike in visits from rodents. Mice, cute as they may be, chew through cords, gnaw into bags of food and leave droppings in cupboards and on counters and floors.

Despite the trackpad’s impressive features, it’s hard to beat a mouse’s precision, comfort, and customizability, especially for graphic design or gaming. While Apple offers the Magic Mouse ...

Dose-response demonstrated for a range of 5 to 80 mg/kg/day achieving up to 38% weight loss in DIO mice Semaglutide treatment followed by its replacement with CRB-913 demonstrated continued weight ...

CRB-913 brain levels are 15-fold lower than monlunabant in lean mice Dose-response demonstrated for a range of 5 to 80 mg/kg/day achieving up to 38% weight loss in DIO mice Semaglutide treatment ...

The data are being presented as a Poster Presentation titled:“Induction and Maintenance Regimens with CB1 Inverse Agonist CRB-913 and Semaglutide in DIO Mice”. “This work adds noteworthy new ...